Home > Insider Trading > Filing (0001458177-18-000001)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
907654	Arca Biopharma Inc.	ABIO	In Vitro & In Vivo Diagnostic Substances (2835)	363855489

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1458177	Venrock Healthcare Capital Partners Lp	3340 Hillview Avenue Palo Alto CA 94304	No	No	Yes	No
1479354	Vhcp Co-Investment Holdings, Llc	3340 Hillview Avenue Palo Alto CA 94304	No	No	Yes	No
1479355	Vhcp Management, Llc	3340 Hillview Avenue Palo Alto CA 94304	No	No	Yes	No
1602263	Vhcp Management Ii, Llc	3340 Hillview Avenue Palo Alto CA 94304	No	No	Yes	No
1602264	Venrock Healthcare Capital Partners Ii, L.p.	3340 Hillview Avenue Palo Alto CA 94304	No	No	Yes	No
1615979	Y Bong Koh	3340 Hillview Avenue Palo Alto CA 94304	No	No	Yes	No
1615983	Vhcp Co-Investment Holdings Ii, Llc	3340 Hillview Avenue Palo Alto CA 94304	No	No	Yes	No
1698082	P Nimish Shah	3340 Hillview Avenue Palo Alto CA 94304	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-02-26	1,500,000	$0.55	41,331	No	4	S	Indirect	By Funds
Common Stock	Disposition	2018-02-27	41,331	$0.53	0	No	4	S	Indirect	By Funds

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Funds
No	4	S	Indirect	By Funds

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.50 to $0.63, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Consists of: 10,482 shares held directly by Venrock Healthcare Capital Partners, L.P. ("VHCP"); 20,585 shares held directly by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"); 1,917 shares held directly by VHCP Co-Investment Holdings, LLC ("Co-Invest"); and 8,347 shares held directly by VHCP Co-Investment Holdings II, LLC ("Co-Invest II").
VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of Co-Invest and may be deemed to beneficially own these shares. VHCP Management II, LLC ("VHCP Management II") is the general partner of VHCP II and the manager of Co-Invest II and may be deemed to beneficially own these shares. Drs. Bong Koh and Nimish Shah are the managing members of VHCP Management and VHCP Management II and may be deemed to beneficially own these shares. Drs. Koh and Shah, VHCP Management and VHCP Management II expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein.